Phase II study of preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in patients with locally advanced gastric and GEJ adenocarcinoma.
Elizabeth Won
No relevant relationships to disclose
David Ilson
Research Funding - Bayer
David Paul Kelsen
No relevant relationships to disclose
Vivian E. Strong
No relevant relationships to disclose
Heiko Schöder
No relevant relationships to disclose
Yelena Yuriy Janjigian
No relevant relationships to disclose
Manish A. Shah
No relevant relationships to disclose
Daniel G. Coit
No relevant relationships to disclose
Murray F. Brennan
No relevant relationships to disclose
Marinela Capanu
No relevant relationships to disclose